EUVIMEDEUVIMED entdecken
Crossref

Effect of Antiplatelet and Anticoagulant Agents on Outcomes Following Emergent Surgery for Traumatic Brain Injuries

Rola Bazzi, Victoria Sharp, Jason Hecht

The American Surgeon™ · 2023

DOI: 10.1177/00031348231157412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, 2023. Verfasst von Rola Bazzi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Inpatient Pharmacy, Trinity Health Ann Arbor, Ypsilant, MI, USA. Hauptthemen laut MEDLINE: Anticoagulants, Brain Injuries, Traumatic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Traumatic brain injury (TBI) is the largest cause of death from injury in the United States. This study utilized the Michigan Trauma Quality Improvement Program (MTQIP) database to determine the effect that antiplatelets and anticoagulants (AP/AC) have on outcomes following emergent surgery for TBI patients. Basic Procedures Patients were included with age ≥18 years, maximum head/neck abbreviated injury score (AIS) ≥2, and underwent a neurosurgical procedure within 24 hours. Patients were excluded if they had an AIS ≥3 in other body region or no signs of life at initial evaluation. Main Findings Within the 1,932 patients analyzed, 139 (8.74%) were in the warfarin with or without (+/-) aspirin cohort, 101 (6.35%) in the direct oral anticoagulants (DOAC) +/− aspirin cohort, 169 (10.62%) in the clopidogrel +/− aspirin cohort, and 1,182 (74.29%) in the no AP/AC cohort (control group). After controlling for demographic and clinical characteristics, no significant difference in mortality rates was observed in the treatment groups ( P > 0.05). However, our subgroup analysis did reveal a significantly higher mortality rate within the warfarin and aspirin subgroup when compared to the control group (odds ratio [OR], 2.368; confidence interval [CI], 1.306-4.294, P = 0.005). With regards to hospital complications, there was a significant increase in this outcome within the DOAC +/− aspirin (OR, 1.825; CI, 1.143-2.915, P = 0.012) and clopidogrel +/− aspirin (OR, 1.82; CI, 1.244-2.663, P=0.002) groups.

Conclusion

Patients on AP/AC who experience a TBI requiring an emergent operation do not have an increased risk of mortality compared to patients not on AP/AC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsBrain Injuries, TraumaticHumansUnited StatesAdolescentPlatelet Aggregation InhibitorsWarfarinClopidogrelRetrospective StudiesAspirin

Stichwörter der Autor:innen

critical caregeneral surgeryintensive care unitpharmacytrauma

Substanzen

AnticoagulantsPlatelet Aggregation InhibitorsWarfarinClopidogrelAspirin

Autor:innen und Institutionen

  • Inpatient Pharmacy, Trinity Health Ann Arbor, Ypsilant, MI, USA.
  • Department of Surgery, Trinity Health Ann Arbor, Ypsilant, MI, USA.

Zitieren

APA

Bazzi, R., Sharp, V., & Hecht, J. (2023). Effect of Antiplatelet and Anticoagulant Agents on Outcomes Following Emergent Surgery for Traumatic Brain Injuries. The American Surgeon™. https://doi.org/10.1177/00031348231157412

Vancouver

Bazzi R, Sharp V, Hecht J. Effect of Antiplatelet and Anticoagulant Agents on Outcomes Following Emergent Surgery for Traumatic Brain Injuries. The American Surgeon™. 2023. doi:10.1177/00031348231157412

BibTeX
@article{Bazzi2023,
  author = {Bazzi, Rola and Sharp, Victoria and Hecht, Jason},
  title = {Effect of Antiplatelet and Anticoagulant Agents on Outcomes Following Emergent Surgery for Traumatic Brain Injuries},
  journal = {The American Surgeon™},
  year = {2023},
  doi = {10.1177/00031348231157412}
}
Kostenlos starten →